Swiss National Bank
TWST icon

Swiss National Bank’s Twist Bioscience TWST Stock Holding History

Swiss National Bank’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.7M Sell
113,800
-5,200
-4% -$338K 0.01% 938
2026
Q1 		$5.65M Hold
119,000
– – ﹤0.01% 1296
2025
Q4 		$3.77M Buy
119,000
+2,900
+2% +$90.5K ﹤0.01% 1512
2025
Q3 		$3.27M Buy
116,100
+2,200
+2% +$66.6K ﹤0.01% 1585
2025
Q2 		$4.19M Sell
113,900
-1,300
-1% -$44.9K ﹤0.01% 1383
2025
Q1 		$4.52M Hold
115,200
– – ﹤0.01% 1323
2024
Q4 		$5.35M Buy
115,200
+1,200
+1% +$54.2K ﹤0.01% 1300
2024
Q3 		$5.15M Hold
114,000
– – ﹤0.01% 1310
2024
Q2 		$5.62M Hold
114,000
– – ﹤0.01% 1202
2024
Q1 		$3.91M Buy
114,000
+900
+0.8% +$32.5K ﹤0.01% 1448
2023
Q4 		$4.17M Sell
113,100
-12,500
-10% -$289K ﹤0.01% 1398
2023
Q3 		$2.54M Buy
125,600
+1,800
+1% +$39.6K ﹤0.01% 1687
2023
Q2 		$2.53M Buy
123,800
+7,900
+7% +$118K ﹤0.01% 1735
2023
Q1 		$1.75M Sell
115,900
-13,400
-10% -$296K ﹤0.01% 1917
2022
Q4 		$3.08M Buy
129,300
+2,600
+2% +$75.4K ﹤0.01% 1624
2022
Q3 		$4.46M Buy
126,700
+1,400
+1% +$59.5K ﹤0.01% 1344
2022
Q2 		$4.38M Buy
125,300
+19,700
+19% +$698K ﹤0.01% 1394
2022
Q1 		$5.21M Buy
105,600
+8,000
+8% +$443K ﹤0.01% 1407
2021
Q4 		$7.55M Buy
97,600
+400
+0.4% +$41.1K ﹤0.01% 1187
2021
Q3 		$10.4M Buy
97,200
+700
+0.7% +$80.2K 0.01% 982
2021
Q2 		$12.9M Buy
96,500
+24,300
+34% +$2.82M 0.01% 892
2021
Q1 		$8.94M Buy
72,200
+1,500
+2% +$228K 0.01% 1066
2020
Q4 		$9.99M Buy
70,700
+5,700
+9% +$632K 0.01% 929
2020
Q3 		$4.94M Buy
65,000
+2,300
+4% +$143K ﹤0.01% 1180
2020
Q2 		$2.84M Buy
62,700
+8,100
+15% +$291K ﹤0.01% 1507
2020
Q1 		$1.67M Buy
54,600
+32,800
+150% +$882K ﹤0.01% 1562
2019
Q4 		$458K Buy
21,800
+1,000
+5% +$23.4K ﹤0.01% 2440
2019
Q3 		$497K Buy
20,800
+10,300
+98% +$299K ﹤0.01% 2363
2019
Q2 		$305K Buy
+10,500
New +$278K ﹤0.01% 2511

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Swiss National Bank's TWST Position: Q2 2026 in Review

Swiss National Bank reduced its Twist Bioscience (TWST) stake by 4.4% in Q2 2026, selling an estimated $338K and leaving 113,800 shares worth $11.7M. The position accounts for 0.01% of the portfolio, ranked #938.

Swiss National Bank first reported a position in TWST in Q2 2019 and has held it in 29 quarters since. The position peaked at $12.9M in Q2 2021. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Swiss National Bank held 113,800 shares of Twist Bioscience worth $11.7M as of Q2 2026.
  • Swiss National Bank sold 5,200 Twist Bioscience shares in Q2 2026, an estimated $338K.
  • Twist Bioscience made up 0.01% of Swiss National Bank's portfolio in Q2 2026, its #938 holding.
  • Swiss National Bank first reported a position in Twist Bioscience in Q2 2019 and has held it in 29 quarters since.
  • Swiss National Bank's Twist Bioscience position peaked at $12.9M in Q2 2021.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.